|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0120 AUD | -7.69% |
|
-14.29% | -20.00% |
| 05-27 | Acrux licenses Lenzetto for Australian market for A$5.4 million | RE |
| 05-27 | Hungary's Richter and Acrux agree to license transdermal estradiol spray for Australia | RE |
Company Valuation: Acrux Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 24.44 | 36.83 | 14.84 | 12.1 | 20.06 | 6.524 |
| Change | - | 50.67% | -59.71% | -18.44% | 65.73% | -67.48% |
| Enterprise Value (EV) 1 | 17.64 | 23.79 | 11.09 | 8.224 | 20.82 | 9.296 |
| Change | - | 34.89% | -53.41% | -25.81% | 153.13% | -55.35% |
| P/E | -2.57x | -2.26x | -1.5x | -15.6x | -3.44x | -0.95x |
| PBR | 1.9x | 1.99x | 1.63x | 1.39x | 6.12x | 6.38x |
| PEG | - | -1.28x | 0x | 0.2x | -0x | 0.1x |
| Capitalization / Revenue | 19.5x | 27.5x | 8.63x | 1.44x | 3.94x | 5.48x |
| EV / Revenue | 14.1x | 17.8x | 6.45x | 0.98x | 4.09x | 7.81x |
| EV / EBITDA | -1.51x | -1.49x | -0.88x | -2.93x | -2.5x | -1.06x |
| EV / EBIT | -1.46x | -1.46x | -0.86x | -2.43x | -2.43x | -1.04x |
| EV / FCF | -2.53x | -2.59x | -1.42x | -6.22x | -4.76x | -1.71x |
| FCF Yield | -39.6% | -38.6% | -70.4% | -16.1% | -21% | -58.5% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0565 | -0.0575 | -0.0346 | -0.0027 | -0.02 | -0.0169 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 1.253 | 1.337 | 1.719 | 8.429 | 5.091 | 1.19 |
| EBITDA 1 | -11.68 | -15.93 | -12.61 | -2.809 | -8.336 | -8.757 |
| EBIT 1 | -12.08 | -16.25 | -12.97 | -3.39 | -8.575 | -8.971 |
| Net income 1 | -9.471 | -12.63 | -9.834 | -0.764 | -5.8 | -5.945 |
| Net Debt 1 | -6.805 | -13.04 | -3.753 | -3.879 | 0.759 | 2.772 |
| Reference price 2 | 0.1450 | 0.1300 | 0.0520 | 0.0420 | 0.0690 | 0.0160 |
| Nbr of stocks (in thousands) | 168,584 | 283,305 | 285,365 | 288,175 | 290,717 | 407,764 |
| Announcement Date | 8/24/20 | 8/25/21 | 8/25/22 | 8/24/23 | 8/28/24 | 8/28/25 |
1AUD in Million2AUD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 4.59M | |
| 38.67x | 7.34x | 25.01x | 0.8% | 47.58B | |
| 18.14x | 2.04x | 9.64x | 1.33% | 35.47B | |
| 28x | 3.46x | 17.73x | 0.86% | 12.42B | |
| 24.59x | 4.26x | 15.85x | 0.72% | 11.83B | |
| 19.07x | 3.28x | 11.93x | 3.58% | 8.79B | |
| 8.43x | 1.98x | 5.19x | 5.14% | 7.09B | |
| 16.24x | 2.07x | 6.96x | 3.25% | 6.99B | |
| 33.19x | 3.77x | 16.06x | 0.24% | 6.53B | |
| 43.87x | - | - | - | 5.4B | |
| Average | 25.58x | 3.53x | 13.55x | 1.99% | 14.21B | |
| Weighted average by Cap. | 27.56x | 4.37x | 16.35x | 1.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ACR Stock
- Valuation Acrux Limited
Select your edition
All financial news and data tailored to specific country editions
